🇺🇸 FDA
Patent

US 11744892

Constrained conditionally activated binding proteins

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 11744892 (Constrained conditionally activated binding proteins) held by Takeda Pharmaceutical Company Limited expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00